|
|
||||||||
Radiology, Vol 207, 431-437, Copyright © 1998 by Radiological Society of North America
ARTICLES |
PD Shreve, RS Steventon, EC Deters, PV Kison, MD Gross and RL Wahl
Department of Nuclear Medicine, Department of Veterans Affairs Medical Center, Ann Arbor, Mich. 48109-0028, USA.
PURPOSE: To compare the performance of a dual-head single photon emission computed tomographic (SPECT) Anger camera operated in coincidence mode with that of a dedicated positron emission tomographic (PET) scanner in the imaging of cancer with 2-[fluorine-18]fluoro-2- deoxy-D-glucose (FDG). MATERIALS AND METHODS: Thirty-one patients with known or suspected malignant neoplasms underwent imaging with both methods, and the images were read blindly. Diagnostic performance on a lesion-by-lesion basis was compared with attenuation-corrected PET as the standard of reference. RESULTS: Of a total of 109 discrete lesions depicted at PET, 60 (relative sensitivity, 55%) were identified on the coincidence-mode images. Of the nodules or masses depicted at PET, 13 (93%) of 14 lung nodules or masses, 20 (65%) of 31 mediastinal lymph nodes, five (71%) of seven lesions in the neck, five (55%) of nine axillary lymph nodes, 11 (50%) of 22 bone metastases, and six (23%) of 26 abdominal tumor deposits were correctly identified on the coincidence gamma camera images. CONCLUSION: These preliminary findings indicate FDG imaging with a modified dual-detector gamma camera operating in coincidence mode can depict many of the lesions depicted with a PET scanner, particularly in the lungs. Sensitivity for lesions detected at dedicated FDG PET was poor in the abdomen and in all locations outside the lungs for tumor deposits generally less than 1.5 cm in short-axis diameter.
This article has been cited by other articles:
![]() |
T. C. Kwee, R. M. Kwee, and R. A. J. Nievelstein Imaging in staging of malignant lymphoma: a systematic review Blood, January 15, 2008; 111(2): 504 - 516. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Acker and S. C. Burrell Utility of 18F-FDG PET in Evaluating Cancers of Lung J. Nucl. Med. Technol., June 1, 2005; 33(2): 69 - 74. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Even-Sapir, B. Yuzefovich, E. Miller, J.-P. Bouhnik, O. Zak, H. Lerman, G. Lievshitz, and C. Levin Coincidence Imaging Using 2 Dual-Head {gamma}-Camera Systems, With and Without Attenuation Correction J. Nucl. Med. Technol., December 1, 2004; 32(4): 190 - 197. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Oturai, J. Mortensen, H. Enevoldsen, A. Eigtved, V. Backer, K. P. Olesen, H. W. Nielsen, H. Hansen, P. Stentoft, and L. Friberg {gamma}-Camera 18F-FDG PET in Diagnosis and Staging of Patients Presenting with Suspected Lung Cancer and Comparison with Dedicated PET J. Nucl. Med., August 1, 2004; 45(8): 1351 - 1357. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Gould, W. G. Kuschner, C. E. Rydzak, C. C. Maclean, A. N. Demas, H. Shigemitsu, J. K. Chan, and D. K. Owens Test Performance of Positron Emission Tomography and Computed Tomography for Mediastinal Staging in Patients with Non-Small-Cell Lung Cancer: A Meta-Analysis Ann Intern Med, December 2, 2003; 139(11): 879 - 892. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Gould, G. D. Sanders, P. G. Barnett, C. E. Rydzak, C. C. Maclean, M. B. McClellan, and D. K. Owens Cost-Effectiveness of Alternative Management Strategies for Patients with Solitary Pulmonary Nodules Ann Intern Med, May 6, 2003; 138(9): 724 - 735. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Kadrmas and P. E. Christian Comparative Evaluation of Lesion Detectability for 6 PET Imaging Platforms Using a Highly Reproducible Whole-Body Phantom with 22Na Lesions and Localization ROC Analysis J. Nucl. Med., November 1, 2002; 43(11): 1545 - 1554. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. J. Lowe and G. A. Wiseman Assessment of Lymphoma Therapy Using 18F-FDG PET J. Nucl. Med., August 1, 2002; 43(8): 1028 - 1030. [Full Text] [PDF] |
||||
![]() |
H Zhang, M Tian, N Oriuchi, T Higuchi, S Tanada, and K Endo Oncological diagnosis using positron coincidence gamma camera with fluorodeoxyglucose in comparison with dedicated PET Br. J. Radiol., May 31, 2002; 75(893): 409 - 416. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Even-Sapir, H. Lerman, A. Figer, M. Rabau, G. Livshitz, M. Inbar, and M. Gutman Role of 18F-FDG Dual-Head Gamma-Camera Coincidence Imaging in Recurrent or Metastatic Colorectal Carcinoma J. Nucl. Med., May 1, 2002; 43(5): 603 - 609. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.F. Vansteenkiste Imaging in lung cancer: positron emission tomography scan Eur. Respir. J., February 1, 2002; 19(35_suppl): 49S - 60s. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Maurea, M. Klain, C. Mainolfi, M. Ziviello, and M. Salvatore The Diagnostic Role of Radionuclide Imaging in Evaluation of Patients with Nonhypersecreting Adrenal Masses J. Nucl. Med., June 1, 2001; 42(6): 884 - 892. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Gambhir, J. Czernin, J. Schwimmer, D. H. S. Silverman, R. E. Coleman, and M. E. Phelps A Tabulated Summary of the FDG PET Literature J. Nucl. Med., May 1, 2001; 42(90050): 1S - 93. [Full Text] [PDF] |
||||
![]() |
J.F. Vansteenkiste and S.G. Stroobants The role of positron emission tomography with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology Eur. Respir. J., April 1, 2001; 17(4): 802 - 820. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tatsumi, H. Kitayama, H. Sugahara, N. Tokita, H. Nakamura, Y. Kanakura, and T. Nishimura Whole-Body Hybrid PET with 18F-FDG in the Staging of Non-Hodgkin's Lymphoma J. Nucl. Med., April 1, 2001; 42(4): 601 - 608. [Abstract] [Full Text] |
||||
![]() |
N J Bird, S E Old, and R W Barber Gamma camera positron emission tomography Br. J. Radiol., April 1, 2001; 74(880): 303 - 306. [Full Text] [PDF] |
||||
![]() |
M. K. Gould, C. C. Maclean, W. G. Kuschner, C. E. Rydzak, and D. K. Owens Accuracy of Positron Emission Tomography for Diagnosis of Pulmonary Nodules and Mass Lesions: A Meta-analysis JAMA, February 21, 2001; 285(7): 914 - 924. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Delbeke, W. H. Martin, J. A. Patton, and M. P. Sandler Value of Iterative Reconstruction,AttenuationCorrection,and Image Fusion in the Interpretation of FDG PET Images with an Integrated Dual-Head Coincidence Camera and X-Ray-based Attenuation Maps Radiology, January 1, 2001; 218(1): 163 - 171. [Abstract] [Full Text] |
||||
![]() |
V. Bousson, J.-L. Moretti, P. Weinmann, N. Safi, F. Tamgac, C. Groiselle, V. de Beco, Y. Hillali, D. Valeyre, and J.-L. Breau Assessment of Malignancy in Pulmonary Lesions: FDG Dual-Head Coincidence Gamma Camera Imaging in Association with Serum Tumor Marker Measurement J. Nucl. Med., November 1, 2000; 41(11): 1801 - 1807. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Fukuchi, K. Hayashida, H. Moriwaki, K. Fukushima, N. Kume, T. Katafuchi, M. Sago, M. Takamiya, and Y. Ishida Brain Fluorine-18 Fluorodeoxyglucose Imaging with Dual-Head Coincidence Gamma Camera:Comparison with Dedicated Ring-Detector PositronEmission Tomography AJNR Am. J. Neuroradiol., January 1, 2000; 21(1): 99 - 104. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Coleman, C. M. Laymon, and T. G. Turkington FDG Imaging of Lung Nodules: A Phantom Study Comparing SPECT, Camera-based PET, and Dedicated PET Radiology, March 1, 1999; 210(3): 823 - 828. [Abstract] [Full Text] |
||||
![]() |
J. E. Blum, H. Handmaker, and N. A. Rinne The Utility of a Somatostatin-Type Receptor Binding Peptide Radiopharmaceutical (P829) in the Evaluation of Solitary Pulmonary Nodules Chest, January 1, 1999; 115(1): 224 - 232. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |